Want to see SG:569 full AI Analyst Report?
Top Page
VicPlas International Ltd.
(SGX:569)
Select Model
Select Model
Rating:42Neutral
Price Target:
S$0.07
▼(-21.11% Downside)
Action:Reiterated
Date:03/24/26
The score is primarily held back by weaker financial performance—recent losses, deteriorating cash generation, and rising leverage—while technicals are mildly negative with the stock below key moving averages. Valuation is also pressured due to a negative P/E and no stated dividend yield.
Positive Factors
Top-line recovery (2025 revenue rebound)
A 44.7% revenue rebound in 2025 shows the business can restore demand and regain sales momentum after a down year. That kind of recovery supports medium-term revenue visibility, helps leverage fixed costs as volumes normalize, and underpins the case for operational recovery if sustained.
Negative Factors
Shift to net losses in 2024–2025
Transitioning from multi-year profitability to net losses weakens internal capital generation and undermines return metrics. Persistent losses erode retained earnings, constrain reinvestment in R&D or sales, and increase reliance on external financing or equity issuance to fund growth and operations over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Top-line recovery (2025 revenue rebound)
A 44.7% revenue rebound in 2025 shows the business can restore demand and regain sales momentum after a down year. That kind of recovery supports medium-term revenue visibility, helps leverage fixed costs as volumes normalize, and underpins the case for operational recovery if sustained.
Read all positive factors
VicPlas International Ltd. (569) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$37.82M
Dividend YieldN/A
Average Volume (3M)97.25K
Price to Earnings (P/E)―
Beta (1Y)0.42
Revenue Growth17.24%
EPS Growth-353.85%
CountrySG
Employees1,000
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding511,537,700
10 Day Avg. Volume66,350
30 Day Avg. Volume97,253
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.65
Price to Sales (P/S)0.39
P/FCF Ratio-7.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VicPlas International Ltd. Business Overview & Revenue Model
Company Description
Vicplas International Ltd, established in Singapore in 1993, operates as an investment holding company with key business segments in medical devices and piping systems. The company's geographical reach includes Singapore, Malaysia, the People's Re...
VicPlas International Ltd. Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
55
Neutral
Cash Flow
34
Negative
| Breakdown | TTM | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.34M | 120.81M | 102.39M | 129.22M | 130.81M | 113.94M |
| Gross Profit | 42.11M | 66.57M | 52.42M | 66.19M | 68.06M | 60.84M |
| EBITDA | 4.35M | 7.01M | 6.93M | 13.18M | 17.93M | 19.03M |
| Net Income | -6.04M | -2.36M | -1.36M | 4.24M | 8.84M | 10.40M |
Balance Sheet | ||||||
| Total Assets | 136.02M | 137.71M | 131.49M | 119.02M | 130.34M | 111.66M |
| Cash, Cash Equivalents and Short-Term Investments | 6.51M | 4.71M | 4.97M | 8.57M | 8.89M | 9.87M |
| Total Debt | 43.91M | 41.11M | 32.47M | 17.55M | 28.01M | 19.57M |
| Total Liabilities | 67.51M | 66.32M | 56.93M | 40.46M | 52.03M | 40.01M |
| Stockholders Equity | 68.51M | 71.39M | 74.57M | 78.56M | 78.31M | 71.64M |
Cash Flow | ||||||
| Free Cash Flow | -2.89M | -5.99M | -7.82M | 12.53M | -2.61M | 3.83M |
| Operating Cash Flow | 1.96M | 388.00K | 6.72M | 17.88M | 10.25M | 9.01M |
| Investing Cash Flow | -632.00K | -6.36M | -14.53M | -5.10M | -12.79M | -5.16M |
| Financing Cash Flow | -2.64M | 5.75M | 4.24M | -12.76M | 1.63M | 1.86M |
VicPlas International Ltd. Technical Analysis
Negative
0.09
Price Trends
0.08
Negative
0.09
Negative
0.09
Negative
Market Momentum
>-0.01
Positive
20.23
Positive
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:569, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.08, and above the 200-day MA of 0.09, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 20.23 is Positive, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:569.
VicPlas International Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
SG:569
VicPlas International Ltd.
0.07
-0.02
-16.85%
SG:505
Asiamedic Limited
0.02
0.01
91.67%
SG:546
Medtecs International Corporation Ltd.
0.12
>-0.01
-8.00%
SG:584
AJJ Medtech Holdings Limited
0.01
0.00
0.00%
SG:MIJ
Alliance Healthcare Group Ltd.
0.16
0.05
51.92%
SG:OTX
Medinex Ltd.
0.23
0.03
15.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.